Correction to: Unintended consequences of decreased PSA-based prostate cancer screening
World J Urol
.
2020 Mar;38(3):807.
doi: 10.1007/s00345-019-02877-6.
Authors
Thomas Ahlering
1
,
Linda My Huynh
2
,
Kamaljot S Kaler
2
,
Stephen Williams
3
,
Kathryn Osann
4
,
Jean Joseph
5
,
David Lee
6
,
John W Davis
7
,
Ronney Abaza
8
,
Jihad Kaouk
9
,
Vipul Patel
10
,
Isaac Yi Kim
11
,
James Porter
12
,
Jim C Hu
13
Affiliations
1
Department of Urology, University of California, Irvine Health, 333 City Blvd West, Suite 2100, Orange, CA, 92868, USA.
[email protected]
.
2
Department of Urology, University of California, Irvine Health, 333 City Blvd West, Suite 2100, Orange, CA, 92868, USA.
3
Division of Urology, Department of Surgery, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
4
Division of Hematology-Oncology, Department of Medicine, University of California, Irvine, Irvine, CA, USA.
5
Department of Urology, University of Rochester, Rochester, NY, USA.
6
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
7
UT MD Anderson Cancer Center, Houston, TX, USA.
8
Department of Urology, Ohio Health Robotic Urologic Surgeons, Dublin, OH, USA.
9
Department of Urology, Cleveland Clinic, Cleveland, OH, USA.
10
Department of Urology, Florida Celebration Health, Kissimmee, FL, USA.
11
Department of Urology, Rutgers Cancer Center of New Jersey, New Brunswick, NJ, USA.
12
Department of Urology, Swedish Medical Center, Seattle, WA, USA.
13
Weill Cornell Medicine, New York, NY, USA.
PMID:
31332511
DOI:
10.1007/s00345-019-02877-6
Abstract
In the original publication, part of funding information was missed.
Publication types
Published Erratum